Skip to main content
HeartCited

Niacin (Vitamin B3) için High Triglycerides (Hypertriglyceridemia)

B Kanıt Bunu büyük ölçüde tutarlı sonuçlarla en az bir randomize çalışma desteklemektedir.

Reduces triglycerides 20-50% dose-dependently. Particularly effective for combined dyslipidemia (high TG + low HDL). Flushing limits adherence with immediate-release forms.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dniacin\u0026condition\u003Dtriglycerides'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
Sonuç

            
            
Reduces triglycerides 20-50% dose-dependently. Particularly effective for combined dyslipidemia (high TG + low HDL). Flushing limits adherence with immediate-release forms.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Randomized Controlled Trial
                
                
                
                12 weeks
                
                
            

            
                Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A …
            
            

                
                Dose: 190 mg/d
                
                
                vs: None
                
                
                Outcome: Cholesterol levels
                
                
                Etki: None
                
                
                p < 0.01
                
            

            
            
Popülasyon: Aged individuals

            
        

        
        

            

                
                    In Vitro
                
                
                
                
            

            
                Immediate-release niacin and a monounsaturated fatty acid-rich meal on postprandial inflammation and monocyte characteristics in …
            
            

                
                Dose: 2 g
                
                
                vs: None
                
                
                Outcome: inflammation markers
                
                
                Etki: None
                
                
                None
                
            

            
            
Popülasyon: Healthy volunteers

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
8

        
Çalışmalar

    

    

        
4000

        
Katılımcılar

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
Derece

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study.
                        
                        
                            
                                RCT
                            
                            
                            
                        
                    

                    

                        Nutrients
                        2024
                        
                        5 atıf
                        
                    

                

                
                

                    

                        
                            Immediate-release niacin and a monounsaturated fatty acid-rich meal on postprandial inflammation and monocyte characteristics in men with metabolic syndrome.
                        
                        
                            
                                Other
                            
                            
                            
                        
                    

                    

                        Clinical nutrition (Edinburgh, …
                        2023
                        
                        11 atıf
                        
                    

                

                
                

                    

                        
                            Hypertriglyceridemia.
                        
                        
                            
                                Other
                            
                            
                            
                        
                    

                    

                        The New England …
                        2008
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
Yaygın Kullanılan Dozajlar

                

                    
                    

                        
generalnutrition:

                        
14-16 mg/day

                    

                    
                    

                        
lipidmodification:

                        
1,000-2,000 mg/day (start at 500 mg/day and titrate)

                    

                    
                

                
                

                    Üst sınır: 35 mg/day for non-prescription use; prescription doses up to 3,000 mg/day under medical supervi
                

                
            

            

            
            

                
Araştırmalarda İncelenen Dozajlar

                

                    

                        
                            

                                Dozaj
                                Süre
                                Etki
                                N
                            

                        
                        
                            
                            

                                190 mg/d
                                12 weeks
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                            

                                2 g
                                --
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                En iyi alım zamanı: With dinner or at bedtime with a low-fat snack; aspirin 30 min before may reduce flushing
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
Bildirilen Yan Etkiler

                    
    
                        
                        
  • 
                            ⚠
                            Flushing (redness, warmth, itching — most common, especially immediate-release)
                        
    • 
                        
                        
  • 
                            ⚠
                            Gastrointestinal discomfort (nausea, diarrhea)
                        
    • 
                        
                        
  • 
                            ⚠
                            Hepatotoxicity (especially extended-release at high doses)
                        
    • 
                        
                        
  • 
                            ⚠
                            Hyperglycemia (may worsen blood sugar control)
                        
    • 
                        
                        
  • 
                            ⚠
                            Hyperuricemia (may precipitate gout)
                        
    • 
                        
                    

                

                

                
                

                    
Bilinen Etkileşimler

                    
    
                        
                        
  • 
                            ●
                            Statins (increased risk of myopathy/rhabdomyolysis)
                        
    • 
                        
                        
  • 
                            ●
                            Blood pressure medications (additive hypotensive effect)
                        
    • 
                        
                        
  • 
                            ●
                            Diabetes medications (may counteract blood sugar control)
                        
    • 
                        
                        
  • 
                            ●
                            Anticoagulants (may increase bleeding risk)
                        
    • 
                        
                        
  • 
                            ●
                            Alcohol (may worsen flushing and hepatotoxicity)
                        
    • 
                        
                    

                

                

                
                

                    

                        Tolere edilebilir üst alım: 35 mg/day for non-prescription use; prescription doses up to 3,000 mg/day under medical supervi
                    

                

                
            

            

                Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Niacin (Vitamin B3) help with High Triglycerides (Hypertriglyceridemia)?
            
        
        

            Based on 8 studies with 4,000 participants, there is moderate evidence from clinical studies that Niacin (Vitamin B3) may support High Triglycerides (Hypertriglyceridemia) management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much Niacin (Vitamin B3) should I take for High Triglycerides (Hypertriglyceridemia)?
            
        
        

            Studies have used various dosages. A commonly studied range is 14-16 mg/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Niacin (Vitamin B3)?
            
        
        

            Reported side effects may include Flushing (redness, warmth, itching — most common, especially immediate-release), Gastrointestinal discomfort (nausea, diarrhea), Hepatotoxicity (especially extended-release at high doses), Hyperglycemia (may worsen blood sugar control). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Niacin (Vitamin B3) and High Triglycerides (Hypertriglyceridemia)?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 8 peer-reviewed studies with 4,000 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  




            

                
                

                    
Şu durum için diğer içerikler: High Triglycerides (Hypertriglyceridemia)

                    

                        
                        
                            Omega-3 Fatty Acids (EPA/DHA)
                            A

                        
                        
                        
                            Omega-7 (Palmitoleic Acid)
                            C

                        
                        
                        
                            Chitosan
                            D

                        
                        
                    

                

                

                
                

                    
Niacin (Vitamin B3) diğer sağlık durumları için

                    

                        
                        
                            High Cholesterol (Hyperlipidemia)
                            B

                        
                        
                    

                

                
            

        

        

    


    
    






  
References

  
    
    
    
  1. 
      [1]
      Evgeny Pokushalov et al..
      Nutrients.
      2024.
      Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study.
      doi:10.3390/nu16132023
      PubMed
    
    2. 
    
    
  2. 
      [2]
      Sergio Montserrat-de la Paz et al..
      Clin Nutr.
      2023.
      Immediate-release niacin and a monounsaturated fatty acid-rich meal on postprandial inflammation and monocyte characteristics in men with metabolic syndrome.
      doi:10.1016/j.clnu.2023.08.017
      PubMed
    
    3. 
    
    
  3. 
      [3]
      Robert Oh.
      N Engl J Med.
      2008.
      Hypertriglyceridemia.
      doi:10.1056/NEJMc072844
      PubMed
    
    4. 
    
  















    

        FDA Sorumluluk Reddi:
        Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.